Dysregulated expression of BCL2 is a hallmark of several B-cell malignancies, including FL and DLBCL, where it often arises from the characteristic t(14; 18) (q32; q21) translocation [74]. The gene discussed is BCL2; the disease is diffuse large B-cell lymphoma.